Showing results (441-450 of 585) with videos related to

Sort By:
Pageof 59
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 19, 2025
Development of Simplified Risk Assessment Scoring System for Sarcopenia in Patients With Chronic Liver DiseaseAtsushi Hiraoka, Hideko Ohama, Fujimasa Tada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 26, 2021
Identification of microRNA-96-5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinomaTakeshi Matsui, Susumu Hamada-Tsutsumi, Yutaka Naito, et al.
Oncology|December 20, 2017
Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma CasesHirofumi Izumoto, Atsushi Hiraoka, Yoshihiro Ishimaru, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 17, 2019
Prediction of risk of falls based on handgrip strength in chronic liver disease patients living independentlyAtsushi Hiraoka, Rumi Tamura, Misato Oka, et al.
Oncology|August 30, 2019
Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular CarcinomaAtsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, et al.
Scientific Reports|July 2, 2016
Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver diseaseHirotaka Shoji, Sachiyo Yoshio, Yohei Mano, et al.
Cancer Medicine|December 17, 2025
Prognostic Stratification of Initial Treatments for Hepatocellular Carcinoma Using a Modified Borderline Resectable ClassificationFujimasa Tada, Atsushi Hiraoka, Hideko Ohama, et al.
European Journal of Gastroenterology & Hepatology|October 11, 2017
Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosisAtsushi Hiraoka, Kojiro Michitaka, Daisuke Kiguchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 30, 2021
Lenvatinib versus Sorafenib as first-line treatment in hepatocellular carcinoma: A multi-institutional matched case-control studyMargherita Rimini, Shigeo Shimose, Sara Lonardi, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 22, 2025
History of Previous Medication Self-Discontinuation Predicts the Current Adherence to 5-Aminosalicylates in Patients With Ulcerative ColitisShogo Kitahata, Ayaka Nakamura, Yuka Kimura, et al.
Pageof 59